RecruitingNot ApplicableNCT04577313

HIV Treatment Adherence Dose Determination Trial

DOSE DETERMINATION TRIAL: The Start/Persist Studies

Sponsor

University of Connecticut

Enrollment

400 participants

Start Date

Sep 1, 2020

Study Type

INTERVENTIONAL

Conditions

HIV Infections

Summary

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing different doses of a digital health intervention designed to help people living with HIV take their antiretroviral (HIV medication) more consistently. Poor adherence to HIV medications can allow the virus to replicate and potentially become drug-resistant. **You may be eligible if...** - You are confirmed HIV-positive - You have been prescribed antiretroviral therapy (ART) - You have been missing doses or are not taking your medication as prescribed - You have access to a phone and the internet **You may NOT be eligible if...** - You do not have access to a phone - You do not have access to the internet Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.